Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes
- 期刊名称Expert Review of Endocrinology & Metabolism
- 作者Tomlinson, Brian; Chan, Paul; Lam, Christopher Wai Kei
- 印刷ISSN1744-6651
- 电子ISSN1744-8417
- 文件大小1430.29KB
- 发表时间2020-04-15
- DOI10.1080/17446651.2020.1750949
- 页码1-11
Pharmacokinetic evaluation of axitinibPatson, Brian; B Cohen, Roger; Olszanski, Anthony J. · Expert Opinion on Drug Metabolism & Toxicology · 2012
Advances in paediatric pharmacokineticsKnibbe, Catherijne AJ; Krekels, Elke HJ; Danhof, Meindert · Expert Opinion on Drug Metabolism & Toxicology · 2011
Introduction to computational oral absorption simulationSugano, Kiyohiko · Expert Opinion on Drug Metabolism & Toxicology · 2009
Pharmacokinetic evaluation of pemetrexedSørensen, Jens Benn · Expert Opinion on Drug Metabolism & Toxicology · 2011
Antisense oligonucleotide pharmacokinetics and metabolismGeary, Richard S · Expert Opinion on Drug Metabolism & Toxicology · 2009
Pharmacokinetic evaluation of pramipexoleAntonini, Angelo; Calandrella, Daniela · Expert Opinion on Drug Metabolism & Toxicology · 2011
Novel methods to assess bioequivalenceKaralis, Vangelis; Symillides, Mira; Macheras, Panos · Expert Opinion on Drug Metabolism & Toxicology · 2011
Pharmacokinetic evaluation of losartanBurnier, Michel; Wuerzner, Grégoire · Expert Opinion on Drug Metabolism & Toxicology · 2011